Salubris Biotherapeutics Inc
6 clinical trials · Sponsor
◉ Watch Salubris Biotherapeutics Inc
| Record | Firm | Date |
|---|---|---|
| Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension (NCT07221513) | Salubris Biotherapeutics Inc | 2025-12-15 |
| Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer (NCT06667960) | Salubris Biotherapeutics Inc | 2024-10-23 |
| Study of JK07 in Patients With Chronic Heart Failure (NCT06369298) | Salubris Biotherapeutics Inc | 2024-03-28 |
| Single-Ascending Dose Study of JK07 in Subjects With HFpEF (NCT05322616) | Salubris Biotherapeutics Inc | 2022-10-21 |
| Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) (NCT04210375) | Salubris Biotherapeutics Inc | 2020-09-21 |
Track Salubris Biotherapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.